Ocular Therapeutix (OCUL) Finished Goods (2014 - 2026)

Ocular Therapeutix's Finished Goods history runs 13 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• In Q1 2026, Finished Goods rose 72.91% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (up 72.91% YoY), while the FY2025 annual figure was $1.6 million, up 22.74% from the prior year.
• Finished Goods was $2.2 million for Q1 2026 at Ocular Therapeutix, up from $1.6 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $2.2 million in Q1 2026 to a low of $343000.0 in Q3 2022.
• Historically, Finished Goods has averaged $1.1 million across 5 years, with a median of $1.2 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Finished Goods surged 198.05% in 2022, then decreased 20.45% in 2024.
• A 5-year view of Finished Goods shows it stood at $766000.0 in 2022, then increased by 29.37% to $991000.0 in 2023, then soared by 34.91% to $1.3 million in 2024, then increased by 22.74% to $1.6 million in 2025, then jumped by 34.55% to $2.2 million in 2026.
• The last three Finished Goods figures came in at $2.2 million (Q1 2026), $1.6 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.